SG Americas Securities, LLC
Broker-DealerPosition in EYPT — EyePoint, Inc.
CIK 1313360
NEW YORK, NY
Position in EYPT
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,269,868
+$1,065,244 QoQ
Shares Held
88,802
+692.9% QoQ
Ownership
0.103%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#77
of 188 holders
Holding Since
Mar 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EYPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SG Americas Securities, LLC holds $1,085,838,933 across 181 Biotechnology names. EYPT ranks #59 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
427,703 | $266,689,928 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
523,720 | $260,147,435 | |
| 3 | URGN |
UroGen Pharma Ltd.
|
2,052,906 | $75,546,940 | |
| 4 | CGON |
CG Oncology, Inc.
|
867,465 | $61,633,388 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
|
605,581 | $49,397,242 | |
| 6 | ASND |
Ascendis Pharma A/S
|
161,026 | $42,948,854 | |
| 7 | RPRX |
Royalty Pharma plc
|
688,590 | $38,609,241 | |
| 8 | BNTX |
BioNTech SE
|
347,131 | $32,300,539 |
All Filings in EYPT
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,269,868 | 88,802 | Shares | Sole | 2026-08-07 | |
| 2025-12-31 | $204,624 | 11,200 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $234,732 | 16,484 | Shares | Sole | 2025-10-23 | |
| 2025-03-31 | $136,909 | 25,260 | Shares | Sole | 2025-04-15 | |
| 2024-09-30 | $154,230 | 19,303 | Shares | Sole | 2024-10-03 | |
| 2024-06-30 | $663,705 | 76,288 | Shares | Sole | 2024-07-12 | |
| 2021-09-30 | $132,531 | 12,719 | Shares | Sole | 2021-11-01 | |
| 2020-03-31 | $25,562 | 25,061 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||